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Abstract
Objective: To determine treatment noncompliance rates among patients participating in a municipal tuberculosis control program and to 
identify the variables related to noncompliance depending on the type of treatment strategy used. Methods: A longitudinal non-concurrent 
cohort study was carried out involving two cohorts of patients participating in the Tuberculosis Control Program of the city of Carapicuíba, 
Brazil. The first cohort comprised 173 patients with tuberculosis treated from January 1, 2003 to December 31, 2003 using self administration 
of treatment, and the second comprised 187 patients with tuberculosis treated from July 1, 2004 to June 30, 2005 using the directly 
observed therapy, short-course strategy. Results: Noncompliance rates decreased from 13.3% (self administration of treatment) to 5.9% 
(directly observed therapy, short-course), a significant difference (p < 0.05). For the self administration of treatment strategy, the variables 
significantly associated with treatment noncompliance were as follows: being an unregistered worker (relative risk [RR] = 3.06); retreatment 
(RR = 2.73); alcoholism (RR = 3.10); and no investigation of contacts (RR = 8.94). For the directly observed therapy, short-course strategy, 
no variables were significantly associated with noncompliance. Conclusion: The directly observed therapy, short-course strategy decreased 
noncompliance rates and produced better treatment outcomes, even when the risk factors for noncompliance were the same.
Keywords: Tuberculosis; Self administration; Directly observed therapy; Treatment refusal. 
Resumo
Objetivo: Verificar as taxas de abandono e identificar as variáveis relacionadas ao abandono do tratamento, segundo o tipo de estratégia 
utilizada em pacientes matriculados no Programa de Controle da Tuberculose do município de Carapicuíba (SP) Brasil. Método: Estudo 
longitudinal não concorrente de duas coortes de tratamento de tuberculose, a primeira de 1 de janeiro a 31 de dezembro de 2003 com a 
estratégia tratamento auto-administrado (173 casos) e a segunda de 1 de julho de 2004 a 30 de junho de 2005 com a estratégia tratamento 
supervisionado (187 casos). Resultados: A taxa de abandono diminuiu significativamente (p < 0,05), de 13,3% (tratamento auto-admin-
istrado) para 5,9% (tratamento supervisionado). Na estratégia tratamento auto-administrado, as variáveis associadas significativamente 
ao abandono foram: estar trabalhando na informalidade (risco relativo [RR] = 3,06); ser caso de retratamento (RR = 2,73); ser alcoolista 
(RR = 3,10); e não ter os contatos examinados (RR = 8,94). Não houve variável associada ao abandono para os casos sob a estratégia trata-
mento supervisionado. Conclusão: A estratégia tratamento supervisionado reduziu a taxa de abandono e produziu bons resultados quanto 
ao desfecho do tratamento, mesmo nos pacientes com fatores de risco para abandono como na coorte tratamento auto-administrado.
Descritores: Tuberculose; Auto-administração; Terapia diretamente observada; Recusa do paciente ao tratamento.
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studies and the training of the municipal health care 
staff, DOTS was implemented in June 2004.
The objective of this study was to determine 
treatment noncompliance rates and the variables 
related to noncompliance of patients with TB 
participating in the Tuberculosis Control Program 
(TCP) of the City of Carapicuíba, comparing those 
using DOTS with those using self administration of 
treatment (SAT).
Methods
A longitudinal non-concurrent cohort study was 
carried out involving two cohorts of reported cases 
of TB that were fully treated (for 6 months) in the 
Local Health Care System of the city of Carapicuíba, 
in the greater metropolitan area of São Paulo. 
Cohort 1 consisted of patients who began treat-
ment between January 1, 2003 and December 31, 
2003 using the SAT strategy. Cohort 2 consisted 
of patients who began treatment between July 1, 
2004 and June 30, 2005 after the implementation 
of the DOTS strategy in the city.
Patients residing in the city and diagnosed with 
TB in accordance with the Technical Guidebook for 
TB Control, in which the use of regimen I or regimen 
IR (retreatment) is recommended, were included in 
the study.(15) 
Patients presenting drug or multidrug resistance 
to regimens I and IR, patients diagnosed with tuber-
culous meningoencephalitis and confirmed cases of 
relocation were excluded from the study. Cases of 
drug or multidrug resistance were excluded because 
they require treatment regimens other than regi-
mens I or IR, and the duration of the treatment is 
longer than six months. For the same reason, cases 
of tuberculous meningoencephalitis and confirmed 
cases of relocation were also excluded due to the 
fact that treatment would be carried out in another 
health care facility.(15)
Introduction
Tuberculosis (TB) is an infectious disease with 
social and demographic features. In large urban 
centers, where population density is high, TB is more 
prevalent and is more frequently associated with 
social indicators of poverty, such as social exclusion, 
low educational level, poor housing, malnutrition, 
difficulties in accessing health care facilities, alco-
holism and concomitant diseases, such as infection 
with HIV.(1-4)
After 1979, Brazil became one of the pioneer 
countries in the treatment of TB by means of a 
public health care program using a short-term (six-
month) regimen designated regimen I.(1,4-6)
Due to the high efficacy of regimen I, it is 
possible to rapidly reduce the transmission of TB 
and, consequently, its incidence. Although the 
Brazilian Unified Health Care System provides free 
medication for TB nationwide, noncompliance with 
the treatment is the greatest obstacle to TB control 
and cure.(5-8)
The World Health Organization (WHO) recom-
mends that noncompliance rates of TB programs be 
lower than 5%. In 2003, the mean noncompliance 
rate was 12% and 10.3% in Brazil and in the state 
of São Paulo, respectively. However, there were huge 
regional differences, ranging from 6.4% in João 
Pessoa to 18.7% in Porto Alegre. In 2004, noncom-
pliance rates were 12.4 and 8.2% in the cities of São 
Paulo and Carapicuíba, respectively.(9-11)
As a worldwide strategy to avoid noncompliance 
and to stimulate the proper use of medication, the 
WHO proposed the directly observed therapy, short-
course (DOTS) strategy, which is a set of political 
and administrative strategies, including supervised 
treatment in order to stimulate compliance with the 
treatment. This is considered one of the best forms 
of intervention in terms of the cost-benefit ratio.
(10-13)
Currently, approximately 50% of TB patients in 
Brazil are being treated using the DOTS strategy. In 
2004, 42.6% of all TB patients in the state of São 
Paulo and 23.2% of all new TB cases in the city of 
São Paulo were treated using this strategy.(11,13,14)
In 2004, the Carapicuíba City Council made an 
agreement with the São Paulo State Department of 
Health and the United States Agency for International 
Development in order to implement the DOTS 
strategy for all TB cases in the city. After various 
Table 1 - Distribution of cases of noncompliance with 
tuberculosis treatment by the type of strategy employed.
Type of 
treatment 
Noncompliance Compliance p RR
n (%) n (%)
SAT 23 (67.6) 150 (46.0)   
DOTS 11 (32.4) 176 (54.0)   
Total 34 (100.0) 326 (100.0) 0.012 2.26
Source: Tuberculosis Control Program of the City of Carapicuíba 
(2003-2005). SAT: self administration of treatment; DOTS: 
directly observed therapy, short-course; and RR: relative risk.
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Whenever necessary, we referred to the Registry of 
TB Cases and Monitoring of their Treatment, stand-
ardized and regulated by the Ministry of Health, or 
to the Registry of Symptomatic Respiratory Cases 
Treated in Health Care Facilities, standardized and 
regulated by the Tuberculosis Control Division of 
the São Paulo State Department of Health Professor 
Alexandre Vranjac Center for Epidemiological 
Surveillance.
The following variables were studied: age; 
gender; level of education; occupation; type of case 
(new or retreatment); clinical form of the disease 
Noncompliance with the treatment was defined 
as when patients with TB, 30 days after treatment 
initiation, missed the follow-up appointment and 
could not be reached, by means of notification or 
home visit, or when the administration of the medi-
cation was interrupted for more than 30 consecutive 
days.(15)
Data regarding the cases of TB were obtained 
from reporting and follow-up forms, available in 
the computerized database of Carapicuíba, as well 
as from the medical charts of patients treated in the 
Municipal Health Care System.
Table 2 - Distribution of patients with tuberculosis using the self administration of treatment strategy by noncompliance/
compliance, according to sociodemographic variables and general aspects of the disease.
Variables
 
SAT (p)
Noncompliance Compliance
n (%) n (%)
Age    
0-20 years 02 (1.2) 16 (9.1)
21-45 years 19 (11.0) 92 (53.2)
≥46 years 02 (1.2) 42 (24.3) 0.111
Gender
Male 18 (10.4) 88 (50.9)
Female 05 (2.9) 62 (35.8) 0.062
Level of education
<8 years of schooling 15 (8.8) 96 (56.5)
≥8 years of schooling 07 (4.1) 52 (30.6) 0.481
Occupation
Homemaker/student 04 (2.4) 39 (22.8)
Registered employee 07 (4.1) 76 (44.4)
Unregistered employee 12 (7.0) 33 (19.3) 0.010
Type of case
New 14 (8.1) 126 (72.8)
Retreatment 09 (5.3) 24 (13.8) 0.013
Clinical form
Pulmonary 20 (11.6) 128 (74.0)
Extrapulmonary 03 (1.7) 22 (12.7) 0.567
Active tuberculosis
Yes 13 (8.8) 97 (65.5)
No 07 (4.8) 31 (20.9) 0.222
Duration of signs/symptoms
<8 weeks 07 (4.1) 61 (35.3)
≥8 weeks 16 (9.2) 89 (51.4) 0.242
Investigation of contacts
Yes 01 (0.7) 49 (31.0)
No 17 (10.7) 91 (57.6) 0.007
Source: Tuberculosis Epidemiology database, Tuberculosis Control Program - Carapicuíba (2003-2005). SAT: self administration of 
treatment.
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Descriptive analysis for the principal variables 
was carried out, as were measurements of central 
tendency for quantitative variables.
In order to identify variables related to noncom-
pliance (bivariate analysis), the dependent variable 
was dichotomized between ‘yes’ or ‘no,’ regarding 
unfavorable outcome (noncompliance with the 
treatment) in the two cohorts (SAT and DOTS).
In order to determine this association, we calcu-
lated the relative risk (RR). The chi-square test or 
Fisher’s exact test were used when indicated. The 
level of significance was set at 5%. Confidence 
intervals were unnecessary, since sampling was not 
used in the study.
The present study was approved by the Ethics 
in Research Committee of the Federal University of 
São Paulo.
Results
During the study period, 360 cases of TB met the 
eligibility criteria. Cohort 1 (SAT) comprised 173 cases 
and cohort 2 (DOTS) comprised 187 cases.
From the final analysis, 39 cases were excluded: 
23 (59%) cases due to confirmed relocation; 
9 (23.1%) due to drug or multidrug resistance; 
4 (10.2%) because the patients resided in other 
cities; and 3 (7.7%) because the patients were diag-
nosed with tuberculous meningoencephalitis.
Of the cases included, 218 (60.6%) were in 
males and 142 (39.4%) were in females, a ratio 
of approximately 1.5:1. This ratio was the same in 
both cohorts. The mean age of the patients using 
SAT was 37.6 years (median, 38 years), compared 
with 37.1 years (median, 38 years) for those using 
DOTS. There was no statistical difference between 
the two cohorts regarding age.
Of the 53 cases of retreatment using SAT or 
DOTS, 42 (79.2%) restarted treatment due to 
previous noncompliance, and 11 (20.8%) restarted 
treatment due to recurrence of TB.
The most common clinical form of TB was the 
pulmonary form (83.6%). Among the extrapulmo-
nary manifestations, the diagnoses were pleural TB 
in 35 (59.3%) patients, peripheral lymph node TB in 
10 (16.9%), miliary TB in 3 (5.1%), osseous TB in 
2 (3.4%) and TB in other locations in 9 (15.3%).
The mean duration of signs and symptoms among 
the patients using SAT was 13 weeks, compared 
with 10 weeks among those using DOTS (median, 
(pulmonary or extrapulmonary); active pulmonary 
TB (positive sputum smear microscopy); duration of 
signs/symptoms prior to diagnosis (in weeks); inves-
tigation of contacts; hospitalizations due to TB; 
and concomitant diseases.
For data collection, individual standardized forms 
were created. These forms were then encoded and 
entered into a specific database using a statistical 
software package (Epi Info 2000, version 3.3). Data 
were entered in duplicate and the Epi Info ‘Validate’ 
tool was used in order to check data consistency 
and eliminate typographical errors.
Table 3 - Distribution of patients with tuberculosis 
using the self administration of treatment strategy by 
noncompliance/compliance, according to hospitalizations 
and concomitant diseases.
Variables
 
SAT  (p)
Noncompliance Compliance
n (%) n (%)
Hospitalization
Yes 02 (1.2) 13 (7.5)
No 21 (12.1) 137 (79.2) 0.623
Concomitant 
diseases
Yes 12 (19.7) 49 (80.3)
No 11 (9.8) 101 (90.2) 0.058
HIV coinfection
Yes 03 (1.7) 06 (3.4)
No 20 (11.7) 144 (83.2) 0.101
Diabetes
Yes 03 (1.7) 13 (7.5)
No 20 (11.6) 137 (79.2) 0.359
Alcoholism
Yes 07 (4.2) 16 (9.2)
No 16 (9.2) 134 (77.4) 0.017
Mental diseases
Yes 01 (0.6) 01 (0.6)
No 22 (12.7) 149 (86.1) 0.249
Hypertension
Yes 0 (0.0) 3 (1.7)
No 23 (13.3) 147 (85.0) 0.650
Other diseases
Yes 00 (0.0) 15 (8.7)
No 23 (13.3) 135 (78.0) 0.106
Source: Tuberculosis Epidemiology database, Tuberculosis Control 
Program - Carapicuíba (2003-2005). SAT: self  administration of 
treatment.
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Table 1 shows that noncompliant cases were 
significantly more common in the SAT group than in 
the DOTS group. The risk of noncompliance with TB 
treatment was approximately 2.3-times higher for 
the patients using SAT than for those using DOTS.
Tables 2 and 3 show the variables possibly 
related to noncompliance of the patients using SAT. 
Being an unregistered worker (RR = 3.06), retreat-
ment (RR = 2.73), no investigation of contacts 
(RR = 8.94), and alcoholism (RR = 3.10) significantly 
contributed to noncompliance with the treatment 
among the patients using SAT.
8 weeks for both cohorts). Of the 360 patients 
evaluated, 32 (8.9%) were hospitalized, primarily 
for ‘diagnostic confirmation’, as was the case for 
18 (56.1%). The second most common reason for 
hospitalization, found for 9 (15.8%) of the patients, 
was respiratory insufficiency. The mean length of 
hospitalization was 14 days.
The most prevalent concomitant diseases in 
both cohorts were alcoholism (in 15%) and diabetes 
mellitus (8.9%). The prevalence of HIV coinfection 
was 5.2% for those using SAT and 4.8% for those 
using DOTS, with no statistical difference.
Table 4 - Distribution of patients with tuberculosis using the directly observed therapy, short-course strategy by 
noncompliance/compliance, according to sociodemographic variables and general aspects of the disease.
Variables
 
DOTS (p)
Noncompliance Compliance
n (%) n (%)
Age
0-20 years 03 (1.6) 23 (12.3)
21-45 years 06 (3.2) 102 (54.5)
≥46 years 02 (1.1) 51 (27.3) 0.377
Gender
Male 06 (3.2) 106 (56.7)
Female 05 (2.7) 70 (37.4) 0.470
Level of education
<8 years of schooling 07 (3.9) 105 (58.3)
≥8 years of schooling 04 (2.2) 64 (35.6) 0.596
Occupation
Homemaker/student 02 (1.4) 50 (27.4)
Registered employee 07 (3.8) 70 (38.5)
Unregistered employee 02 (1.4) 51 (27.5) 0.336
Type of case
New 08 (4.3) 159 (85.0)
Retreatment 03 (1.5) 17 (9.2) 0.099
Clinical form
Pulmonary 10 (5.3) 143 (76.5)
Extrapulmonary 01 (0.6) 33 (17.6) 0.354
Active tuberculosis
Yes 07 (4.6) 94 (61.8)
No 03 (2.0) 48 (31.6) 0.553
Period of signs/symptoms
<8 weeks 04 (2.3) 88 (47.0)
≥8 weeks 07 (3.7) 88 (47.0) 0.287
Investigation of contacts
Yes 05 (3.1) 107 (64.4)
No 05 (3.1) 49 (29.4) 0.190
Source: Tuberculosis Epidemiology database, Tuberculosis Control Program - Carapicuíba (2003-2005). DOTS: directly observed 
therapy, short-course.
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impossible and unnecessary in the simultaneous 
comparison between the two strategies, since DOTS 
has shown a better cost-benefit ratio in various 
studies in the literature.(11,13)
Our results show that noncompliance rates were 
significantly lower among patients using DOTS than 
among those using SAT, almost reaching the target 
rate of 5% recommended by the Brazilian National 
TCP and the WHO. As previously mentioned, the risk 
of noncompliance was 2.3-times higher for those 
using SAT than for those using DOTS. These data 
indicate that the Carapicuíba TCP benefited from 
the implementation of DOTS and corroborate the 
results of other studies.(3,10,16)
To ensure the regularity of the administration of 
medication and to maintain treatment throughout 
the recommended period have been the critical 
points for the success of standardized therapeutic 
regimens for TB and the control of the chain of 
transmission. Strategies such as DOTS or other 
possible adapted variations, depending on the local 
characteristics, particularities and conditions, should 
be developed and improved, based on the promising 
results of DOTS and other programs for the control 
of TB.(5,9,11,16,17)
Most of the patients studied were from 21 to 
45 years of age, which is considered to be the most 
economically productive age bracket, and males 
predominated, as did a low level of education, 
although none of these sociodemographic variables 
presented a significant association with noncom-
pliance in either of the cohorts studied. However, 
being an unregistered worker, typically with a low 
salary and having had little education, was associ-
ated with noncompliance in the cohort using the 
SAT strategy, a finding that is in agreement with 
those of other studies.(7,8,18-20)
Some studies have shown that being in retreat-
ment (due to noncompliance or recurrence) is 
strongly associated with noncompliance. This asso-
ciation was also found in the present study for the 
cases using SAT,(8,17) but not for those using DOTS.
Alcoholism was the most highly prevalent comor-
bidity in the present study and was significantly 
associated with noncompliance among TB cases 
using SAT. In addition, studies in the literature have 
shown that alcoholism is an significant risk factor 
for poor prognosis and unfavorable outcome in the 
treatment of TB.(7,20-23)
Tables 4 and 5 show that there was no signifi-
cant association between those same variables and 
noncompliance with the treatment among the 
patients using DOTS.
Discussion
In the present longitudinal study, two non-
concurrent cohorts were compared, according 
to the treatment/strategy used: SAT or DOTS. 
In Carapicuíba, the implementation of DOTS, a 
strategy supported by the literature, recommended 
by WHO for developing countries and encouraged 
by the Ministry of Health, has made randomization 
Table 5 - Distribution of patients with tuberculosis using 
the directly observed therapy, short-course strategy by 
noncompliance/compliance, according to hospitalizations 
and concomitant diseases.
Variables
 
DOTS (p)
Noncompliance Compliance
n (%) n (%)
Hospitalization
Yes 00 (0.0) 42 (22.4)
No 11 (6.0) 134 (71.6) 0.056
Concomitant 
diseases
Yes 04 (5.7) 66 (94.3)
No 07 (6.0) 110 (94.0) 0.605
HIV coinfection
Yes 00 (0.0) 09 (4.8)
No 11 (5.9) 167 (89.3) 0.572
Diabetes
Yes 00 (0.0) 16 (8.5)
No 11 (5.9) 160 (85.6) 0.363
Alcoholism
Yes 03 (1.6) 28 (15.0)
No 08 (4.3) 148 (79.1) 0.267
Mental diseases
Yes 00 (0.0) 04 (2.1)
No 11 (5.9) 172 (92.0) 0.783
Hypertension
Yes 0 (0.0) 08 (4.2)
No 11 (5.9) 168 (89.9) 0.610
Other diseases
Yes 02 (1.1) 13 (6.9)
No 09 (4.8) 163 (87.2) 0.217
Source: Tuberculosis Epidemiology database, Tuberculosis Control 
Program - Carapicuíba (2003-2005).DOTS: directly observed 
therapy, short-course.
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Another significant aspect regarding noncom-
pliant patients using SAT was the fact that, 
when fewer contacts were investigated, the 
rates of noncompliance with the treatment were 
higher. Therefore, social and family support is 
presumed to have a positive influence on treatment 
outcomes.(8,18,23)
Knowledge of the disease and the demys-
tification of beliefs regarding its treatment are 
significant factors for compliance, and the health 
care staff should monitor the participation of the 
family throughout the treatment. In addition, the 
patient is not the only individual to be affected by 
the disease.(24)
After the implementation of DOTS and the 
resulting decrease in noncompliance rates, no 
association between noncompliant patients using 
DOTS and any of the variables studied was found, 
which might be attributable to the lower number 
of noncompliant patients. In general, the lower 
noncompliance rate among patients using DOTS 
might be related to the more intimate, frequent 
and humanized contact between patients and the 
entire health care staff, resulting in a stronger bond 
between patients, their companions, families and the 
health care facility, as well as in better compliance 
with the therapeutic regimen and more favorable 
treatment outcomes, although the political admin-
istrative infrastructure as a whole also plays a role in 
improving the performance of the TCP.(8,11,14,17,19,25)
Political, administrative, organizational and 
social changes, involving health care centers, the 
community, families and the media, are neces-
sary. Ultimately, health care professionals should be 
trained and sensitized, by means of training courses 
and continuing education regarding DOTS. These 
will promote the more efficacious performance of 
TB control programs.
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